49. Systemic lupus erythematosus Clinical trials / Disease details

Clinical trials : 993 / Drugs : 702 - (DrugBank : 184) / Drug target genes : 116 - Drug target pathways : 200

14 trials found

diseases per page:

Showing 1 to 10 of 14 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05672576 (ClinicalTrials.gov)	January 16, 2023	3/1/2023	A Research Study to Evaluate the Efficacy and Safety of Cenerimodin Subjects Suffering From Systemic ...	A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evalua ...	Lupus Erythematosus, Systemic	Drug: Cenerimod;Drug: Placebo	Idorsia Pharmaceuticals Ltd.	NULL	Recruiting	18 Years	75 Years	All	420	Phase 3	United States
2	NCT05648500 (ClinicalTrials.gov)	December 13, 2022	5/12/2022	A Research Study to Evaluate the Effects of a New Oral Medicine Called Cenerimodin Adults With Syste ...	A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evalua ...	Lupus Erythematosus, Systemic	Drug: Cenerimod;Drug: Placebo	Idorsia Pharmaceuticals Ltd.	NULL	Recruiting	18 Years	75 Years	All	420	Phase 3	United States
3	JPRN-jRCT2011210019	06/11/2021	30/06/2021	Phase 2 double blind study of cenerimod	A randomized, double-blind, parallel-group, multicenter, phase 2 study to investigate the safety and ...	Systemic lupus erythematosus	Administration of two doses of cenerimod(2 and 4 mg) given orally once daily for 3 months in adult s ...	Yokoyama Yoshinari	NULL	Not Recruiting	>= 18age old	<= 75age old	Both	16	Phase 2	Japan
4	EUCTR2018-001808-11-GR (EUCTR)	29/07/2020	16/07/2020	A research study to evaluate the effects of a new oral drug called cenerimodin adults with Systemic ...	A Phase 2b, multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evalu ...	Moderate to severe systemic lupus erythematosus MedDRA version: 21.1;Level: PT;Classification code 1 ...	Product Name: Cenerimod Product Code: ACT-334441 INN or Proposed INN: Cenerimod Other descriptive name: ...	Idorsia Pharmaceuticals Ltd	NULL	Not Recruiting			Female: yes Male: yes	325	Phase 2	United States;Czechia;Philippines;Taiwan;Greece;Spain;Thailand;Ukraine;Turkey;Chile;Israel;Russian F ...
5	EUCTR2018-001808-11-DE (EUCTR)	04/10/2019	18/10/2018	A research study to evaluate the effects of a new oral drug called cenerimodin adults with Systemic ...	A Phase 2b, multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evalu ...	Moderate to severe systemic lupus erythematosus MedDRA version: 21.1;Level: PT;Classification code 1 ...	Product Name: Cenerimod Product Code: ACT-334441 INN or Proposed INN: Cenerimod Product Name: Cenerimod ...	Idorsia Pharmaceuticals Ltd	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	500	Phase 2	United States;Taiwan;Thailand;Spain;Ukraine;Turkey;Israel;Russian Federation;United Kingdom;Italy;Fr ...
6	EUCTR2018-001808-11-PL (EUCTR)	17/05/2019	15/05/2019	A research study to evaluate the effects of a new oral drug called cenerimodin adults with Systemic ...	A Phase 2b, multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evalu ...	Moderate to severe systemic lupus erythematosus MedDRA version: 21.1;Level: PT;Classification code 1 ...	Product Name: Cenerimod Product Code: ACT-334441 INN or Proposed INN: Cenerimod Product Name: Cenerimod ...	Idorsia Pharmaceuticals Ltd	NULL	Not Recruiting			Female: yes Male: yes	325	Phase 2	Georgia;Germany;Romania;Bulgaria;United States;Philippines;Czechia;Taiwan;Greece;Spain;Thailand;Ukra ...
7	EUCTR2018-001808-11-BG (EUCTR)	20/03/2019	06/12/2018	A research study to evaluate the effects of a new oral drug called cenerimodin adults with Systemic ...	A Phase 2b, multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evalu ...	Moderate to severe systemic lupus erythematosus MedDRA version: 21.1;Level: PT;Classification code 1 ...	Product Name: Cenerimod Product Code: ACT-334441 INN or Proposed INN: Cenerimod Product Name: Cenerimod ...	Idorsia Pharmaceuticals Ltd	NULL	Not Recruiting			Female: yes Male: yes	325	Phase 2	United States;Philippines;Czechia;Taiwan;Greece;Spain;Thailand;Ukraine;Turkey;Chile;Israel;Russian F ...
8	EUCTR2018-001808-11-HU (EUCTR)	08/02/2019	22/11/2018	A research study to evaluate the effects of a new oral drug called cenerimodin adults with Systemic ...	A Phase 2b, multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evalu ...	Moderate to severe systemic lupus erythematosus MedDRA version: 20.0;Level: PT;Classification code 1 ...	Product Name: Cenerimod Product Code: ACT-334441 INN or Proposed INN: Cenerimod Product Name: Cenerimod ...	Idorsia Pharmaceuticals Ltd	NULL	Not Recruiting			Female: yes Male: yes	500	Phase 2	United States;Taiwan;Thailand;Spain;Ukraine;Turkey;Lithuania;Russian Federation;Israel;United Kingdo ...
9	EUCTR2018-001808-11-IT (EUCTR)	07/02/2019	28/01/2021	A research study to evaluate the effects of a new oral drug called cenerimodin adults with Systemic ...	A Phase 2b, multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evalu ...	Moderate to severe systemic lupus erythematosus MedDRA version: 21.1;Level: PT;Classification code 1 ...	Product Name: Cenerimod Product Code: [ACT-334441] INN or Proposed INN: Cenerimod Product Name: Cenerim ...	IDORSIA PHARMACEUTICALS LTD	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	500	Phase 2	United States;Czechia;Philippines;Taiwan;Greece;Spain;Thailand;Ukraine;Turkey;Chile;Israel;Russian F ...
10	EUCTR2018-001808-11-ES (EUCTR)	24/01/2019	16/11/2018	A research study to evaluate the effects of a new oral drug called cenerimodin adults with Systemic ...	A Phase 2b, multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evalu ...	Moderate to severe systemic lupus erythematosus MedDRA version: 20.0;Level: PT;Classification code 1 ...	Product Name: Cenerimod Product Code: ACT-334441 INN or Proposed INN: Cenerimod Product Name: Cenerimod ...	Idorsia Pharmaceuticals Ltd	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	500	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - ( ...	United States;Hong Kong;Taiwan;Spain;Thailand;Ukraine;Lithuania;Turkey;Russian Federation;Israel;Ita ...

First Previous1 2Next Last